Medical and ethical issues in genetic screening--an academic view.
Open Access
- 1 October 1996
- journal article
- Published by Environmental Health Perspectives in Environmental Health Perspectives
- Vol. 104 (suppl 5), 987-990
- https://doi.org/10.1289/ehp.96104s5987
Abstract
This article is intended to acquaint those whose principal concerns are the health and safety of workers with genetic screening and some of the medical and ethical issues it raises. Population-based genetic screening increasingly is being considered for predicting future disease in the person being screened. A major problem in screening for alleles that contribute to the development of common, multifactorial disorders is low sensitivity and positive predictive value. In many instances, no demonstrably effective prophylaxis or treatment is available to help those with positive test results. This creates ethical problems of assuring that testing is in the person's best interest and raises in turn issues of autonomy, discrimination, and privacy. Instead of screening for genetic predispositions to harm from workplace exposures, other means of improving the health of workers may bring greater benefits to a higher proportion of workers. The current state of genetic tests for chronic beryllium disease are considered. None are suitable for screening.Keywords
This publication has 12 references indexed in Scilit:
- Chronic beryllium disease: diagnosis and management.Environmental Health Perspectives, 1996
- Genetic testing: employability, insurability, and health reform.1995
- Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization.1994
- Chronic Beryllium Disease—From the Workplace to Cellular Immunology, Molecular Immunogenetics, and BackClinical Immunology and Immunopathology, 1994
- Attitudes Toward Direct Predictive Testing for the Huntington Disease GeneJAMA, 1993
- Re: Lung Cancer Incidence Among Patients With Beryllium DiseaseJNCI Journal of the National Cancer Institute, 1993
- Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.1993
- State legislative efforts to regulate use and potential misuse of genetic information.1992
- Eugenics and genetic discrimination.1992
- What Drives Neonatal Screening Programs?New England Journal of Medicine, 1991